Advertisement

Topics

Video News: Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury

02:00 EDT 18 Aug 2017 | InvestorIdeas

August 18, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and biotech stocks releases a video/ interview featuring David Schrader, Chief Operating Officer of Scythian Biosciences (TSX.V: SCYB), a company developing a drug regimen for concussion and traumatic brain injury using a cannabinoid-based combination drug therapy.

Original Article: Video News: Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury

NEXT ARTICLE

More From BioPortfolio on "Video News: Scythian Biosciences (TSX.V: $SCYB.V) Discusses #Cannabinoid-based Treatment for #Concussion and Traumatic Brain Injury"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...